Agrivalle Partners Ginkgo Bioworks To Advance Its Biological Products

Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.

RTTNews | 357天前

Imagindairy And Ginkgo Bioworks Partner To Develop Animal-Free Non-Whey Dairy Proteins

Israeli-based foodtech company Imagindairy and Ginkgo Bioworks (DNA) announced Tuesday a new partnership with the aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner.

RTTNews | 373天前

Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.

RTTNews | 449天前

NAMUH, Ginkgo Bioworks Ink Partnership To Develop Functional Oligosaccharides

Infant nutrition company NAMUH and Ginkgo Bioworks Holdings, Inc. (DNA) announced Wednesday a multi-product collaboration to develop functional oligosaccharides that are structurally identical to those found in human breast milk.

RTTNews | 806天前

Ginkgo Bioworks Acquires Biotechnology Company Circularis For Undisclosed Terms

Ginkgo Bioworks (DNA), the leading horizontal platform for cell programming, announced Tuesday the tuck-in acquisition of Circularis, a biotechnology company with a proprietary circular RNA and promoter screening platform.

RTTNews | 912天前

Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.

RTTNews | 983天前

Asian Markets Track Wall Street Lower

Asian stock markets are trading mostly lower on Friday, following the broadly negative from Wall Street overnight, with some of the major markets being closed, as traders continue to assess the impact of the steeper-than-expected reciprocal tariffs imposed by US President Donald Trump on U.S. trade partners. Asian markets ended mostly lower on Thursday.

RTTNews | 4小时6分钟前

Australian Market Extends Early Losses In Mid-market

The Australian stock market is extending its early losses in mid-market moves on Friday, adding to the losses in the previous session, following the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling almost 2 percent to stay just above the 7,700 level, with weakness across most sectors led by energy and technology stocks.

RTTNews | 4小时49分钟前

EURUSD	1.10801	GBPUSD	1.30938	AUDUSD	0.6251
USDJPY	145.802	USDCAD	1.40954	USDCHF	0.85469

Advertisement

Agrivalle Partners Ginkgo Bioworks To Advance Its Biological Products